The Caesars Sportsbook promo code CBS250BM offers new users a first bet matched up to $250 as a bonus bet, win or lose. Sunday's NFL schedule is the perfect time to take advantage of that offer, ...

Apple has announced a new limited-time Apple Pay promotion. The company says you can save 20% on online orders from Adidas when you check out with Apple Pay. Apple announced the promotion in an email ...

The Centers for Disease Control and Prevention’s vaccine advisory panel on Friday rolled back a decadeslong recommendation that all newborns get a first dose of the hepatitis B vaccine within 24 hours ...

The latest Fanatics Sportsbook promo code CBSFAN offers new users the chance to bet and get up to $2,000 in No Sweat Bets in FanCash. NFL fans will have one final opportunity to lock in wagers on ...

Provided enough time, all things will inevitably become a roguelike. It is the way of things, a truth of the universal mathematics revealed in countless Steam listings. Everything inevitably becomes ...

EV drivers across Illinois can now access flat-rate fast charging for $15 per session, thanks to Universal EV Chargers’ new no-hidden-fee pricing. That means drivers can plug in, power up, and get ...

Grant Davis has shared an in-depth 20-minute video detailing the trials and errors of building an old-school CRT combo TV out of Lego that mechanically recreates the iconic bouncing logo screensaver ...

New Mexico will become the first state in the country to begin offering free universal child care, Democratic Gov. Michelle Lujan Grisham announced. The move amounts to an expansion of an existing ...

Ford claims its new midsize EV pickup will have a lower cost of ownership than a Tesla Model Y and more space than a Toyota RAV4. Starting at $30,000, it will also cost about the same as the RAV4.

Universal Studios Hollywood has completed its 2025 Halloween Horror Nights lineup with the announcement of additional scares inspired by Poltergeist, The Purge and Blumhouse. The Poltergeist-themed ...

A new type of immunotherapy that targets aggressive blood cancers shows promising results alongside manageable side effects, according to the results of an international phase 1/2 clinical trial led ...